Piper Sandler reduced its price target on Jazz Pharmaceuticals to $163, maintaining an Overweight rating.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Piper Sandler reduced its price target on Jazz Pharmaceuticals to $163, maintaining an Overweight rating.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.